Company / Operating Income per Share
Altimmune, Inc. Operating Income per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.31
FY2025
5-year range
-$2.36 / -$1.31
FY2021-FY2025
Trend
+3.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has increased for 3 consecutive years, from $-2.36 in FY2022 to $-1.31 in FY2025.
Based on SEC 10-K filings.
-1.31 in FY2025.
Improved from $-1.78 to $-1.31 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Altimmune, Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 3.8% year-over-year.
- Peak operating income per share was recorded in FY2011.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.31 | +3.8% |
| FY2024 | -$1.36 | +23.9% |
| FY2023 | -$1.78 | +24.6% |
| FY2022 | -$2.36 | -60.2% |
| FY2021 | -$1.48 | -5.2% |
| FY2020 | -$1.40 | +70.3% |
| FY2019 | -$4.72 | +94.5% |
| FY2018 | -$85.53 | -5234.0% |
| FY2017 | -$1.60 | -214.8% |
| FY2011 | -$0.51 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026